Caldan Therapeutics is a startup based in the United Kingdom.
Caldan Therapeutics is a startup based in the United Kingdom.
Caldan Therapeutics is a university spin-out developing novel therapeutics that target free fatty acid receptors for metabolic diseases. Its lead programme is a selective FFA4 (GPR120) agonist aimed at treating Non-Alcoholic Steatohepatitis (NASH).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.